Budget impact analysis of the adoption of new hypertension guidelines in Colombia-Reference-Cited by-同舟云学术

Budget impact analysis of the adoption of new hypertension guidelines in Colombia

Published:2018-09-25 Issue:1 Volume:16 Page:
ISSN:1478-7547
Container-title:Cost Effectiveness and Resource Allocation
language:en
Short-container-title:Cost Eff Resour Alloc

Author:

Guevara-Cuellar Cesar Augusto,Soto Victoria Eugenia,Molina-Echeverry María Isabel

Publisher

Springer Science and Business Media LLC

Subject

Health Policy

Link

http://link.springer.com/content/pdf/10.1186/s12962-018-0152-5.pdf

Reference40 articles.

1. Ministerio de Salud y Protección Social. Día Mundial de la Hipertensión Arterial - Ficha técnica. Minist. Salud y Protección Soc. 2017. https://www.minsalud.gov.co/sites/rid/Lists/BibliotecaDigital/RIDE/VS/PP/ENT/dia-mundial-hipertension-2017.pdf . Accessed 2 Feb 2018.

2. Stevens B, Verdian L, Pezzullo L, Tomlinson J, Zegenhagen S. The economic burden of hypertension in Latin America. Value Health. 2016;19:647–8.

3. Whelton PK, Carey RM, Aronow WS, Casey DE, Collins KJ, Dennison Himmelfarb C, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Pr. Hypertension. American Heart Association, Inc. 2017.

4. Wander GS, Ram CVS. Global impact of 2017 American Heart Association/American College of Cardiology hypertension guidelines: a perspective from India. Circulation. 2018;137:549–50.

5. Kario K. Global impact of 2017 American Heart Association/American College of Cardiology hypertension guidelines: a perspective from Japan. Circulation. 2018;137:543–5.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The power of health economics and outcomes research (HEOR) in making decisions that matter;Magna Scientia UCEVA;2021-10-25

2. Adoption of hypertension guideline would decrease healthcare costs;PharmacoEconomics & Outcomes News;2018-10